Navigation Links
New details on microtubules and how the anti-cancer drug Taxol works
Date:5/22/2014

45;-tubulin that is buried, and an "E-site" on the β-tubulin that is exposed when the tubulin is depolymerized. Previous microtubule reconstruction studies were unable to distinguish the highly similar α-tubulin and β-tubulin from each other.

"To be able to distinguish the α-tubulin from the β-tubulin, we had to resolve our images at better than 8 , which most prior cryo-EM studies were unable to do," Nogales says. "For that, we marked the subunits with kinesin, a protein motor that distinguishes between α- and β-tubulin."

Nogales and her colleagues found that GTP hydrolysis and the release of the phosphate (GTP becomes GDP) leads to a compaction of the E-site and a rearrangement of the α-tubulin monomer that generates a strain on the microtubule that destabilizes its structure. Taxol binding leads to a reversal of this E-site compaction and α-tubulin rearrangement that restores structural stabilization.

"Remarkably, Taxol binding globally reverses the majority of the conformational changes we observe when comparing the GMPCPP and GDP states," Nogales says. "We propose that GTP hydrolysis leads to conformational strain in the microtubule that would be released by bending during depolymerization. This model is consistent with the changes we observe upon taxol binding, which dramatically stabilizes the microtubule lattice. Our analysis supports a model in which microtubule-stabilizing agents like Taxol modulate conformational strain and longitudinal contacts in the microtubule lattice."


'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Scientists uncover startlingly new functional details of common anti-diabetic drugs
2. Report details multiple commercial uses of wireless sensor networks
3. Quantum effects help cells capture light, but the details are obscure
4. Wonder of Nanotechnology details research enabling nanoscale optoelectronic devices
5. Demand for details on food labels includes the good -- and the bad
6. Study details paired risk factors in preeclampsia
7. Biologists uncover details of how we squelch defective neurons
8. Scientists discover new details about rice blast, a deadly plant fungus
9. Prehistoric ghosts revealing new details
10. New book details the biological and cultural diversity of Khawa Karpo, sacred mountain of Tibet
11. Study details essential role of trust in agricultural biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New details on microtubules and how the anti-cancer drug Taxol works
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication ... success of the Wocket™ smart wallet at CES 2015 in ... as one of the "11 Hot Products at CES" in a review ... So Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" ...
(Date:1/22/2015)... YORK , Jan. 22, 2015   EyeLock, Inc. , ... it has appointed Steve Gerber to the new ... will be responsible for leading development of mobile platforms and ... years of success and innovation in the semiconductor industry to ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... MENLO PARK, Calif. October 4, 2010 ... on women,s reproductive health, today announced that it acquired ... set of products that may allow medical practitioners in ... effectiveness of in vitro fertilization (IVF) procedures. The ...
... obese adolescents, particularly females, are undergoing gastric bypass surgery. ... the American Academy of Pediatrics (AAP) National Conference and ... gastric bypass surgery in adolescent girls and an increased ... varying degrees of disability such as paralysis and mental ...
... MIAMI Nonwhite women reported receiving less social support ... presented at the Third AACR Conference on The Science ... "This is an important finding when designing and ... better include cancer survivors of color," said study author ...
Cached Biology News:Auxogyn licenses noninvasive embryo assessment technology from Stanford University 2Loss of nutrients following gastric bypass surgery in adolescent girls 2Social support post-cancer lacking among minority women 2
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015  23andMe, ... of Kate Black as Privacy Officer and ... federal, and state privacy laws as well as health ... regulatory team, she will be responsible for reviewing, updating ... customers in the U.S. and abroad. She joined the ...
(Date:2/26/2015)... Feb. 26, 2015 DuPont Executive Vice President ... by key research advancements and product launches across the ... of America Merrill Lynch 2015 Global Agriculture Conference. ... building grain supplies the last two years, long-term demand ... pace of the last decade, when demand for corn ...
(Date:2/26/2015)... Feb. 26, 2015 BioEnterprise today announced that ... attracted more than $2 billion in growth funding during ... national investors, strategic sources, state – including the Ohio ... the $2 billion has been raised in the past ... the heels of the BioEnterprise Midwest Healthcare Growth ...
(Date:2/26/2015)... 2015 According to a new market ... For Transgenic Crops (Corn, Soybean, Cotton and Others), Synthetic ... Share, Growth, Trends and Forecast, 2013 – 2019,”the global ... in 2012 and is expected to reach USD 28,694.1 ... from 2013 to 2019. , Demand for food ...
Breaking Biology Technology:23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today ... September 30, 2011. (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ... third quarter of 2011 of $11.1 million, compared $669,000 ... product sales of $10.6 million recognized from the sale ...
... Vermillion, Inc. (NASDAQ: VRML ), a leading ... the United States Patent and Trademark Office for its fifth ... in the diagnosis of Peripheral Artery Disease (PAD), a condition ... The patent, entitled "Beta-2 Microglobulin (B2m) and C Reactive ...
... 2011 Caliper Life Sciences, Inc. (NASDAQ: CALP ... ended September 30, 2011.  Third quarter revenue increased 24% to ... 2010.  Organic revenue, which excludes the effects of acquisitions, divestitures ... of 2010 and 21% on a year-to-date basis.  Caliper reported ...
Cached Biology Technology:Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 2Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 3Caliper Life Sciences Reports Third Quarter 2011 Results 2Caliper Life Sciences Reports Third Quarter 2011 Results 3Caliper Life Sciences Reports Third Quarter 2011 Results 4Caliper Life Sciences Reports Third Quarter 2011 Results 5Caliper Life Sciences Reports Third Quarter 2011 Results 6Caliper Life Sciences Reports Third Quarter 2011 Results 7Caliper Life Sciences Reports Third Quarter 2011 Results 8Caliper Life Sciences Reports Third Quarter 2011 Results 9Caliper Life Sciences Reports Third Quarter 2011 Results 10Caliper Life Sciences Reports Third Quarter 2011 Results 11Caliper Life Sciences Reports Third Quarter 2011 Results 12Caliper Life Sciences Reports Third Quarter 2011 Results 13Caliper Life Sciences Reports Third Quarter 2011 Results 14Caliper Life Sciences Reports Third Quarter 2011 Results 15Caliper Life Sciences Reports Third Quarter 2011 Results 16Caliper Life Sciences Reports Third Quarter 2011 Results 17Caliper Life Sciences Reports Third Quarter 2011 Results 18Caliper Life Sciences Reports Third Quarter 2011 Results 19